Contemporary indications for percutaneous revascularization of coronary chronic total occlusions

Abstract

Chronic total occlusions (CTO) are frequently encountered during coronary angiography, and are generally regarded as the most challenging coronary lesions for percutaneous coronary intervention (PCI). Despite great technical advancements and greatly improved reported procedural success rates during previous years, data on clinical benefit of these procedures still remain scarce and controversial. Data from observational trials suggested that PCI for CTO could be linked to improvements both in symptoms and hard cardiovascular outcomes, while randomized controlled trials showed symptomatic improvement only, without improvement in patient’s prognosis. This is in parallel with findings for non-CTO PCI in patients with stable angina. Having in mind complexity of these interventions, high costs, greater volume of contrast, and radiation exposure, appropriate patient selection is crucial for optimizing treatment effectiveness. There are few important factors that should be taken into consideration before planning and attempting PCI for CTO. These are: severity of patient’s symptoms despite optimal medical therapy, presence of inducible myocardial ischemia and/or viability in the territory of occluded coronary artery.

Keywords

Chronic total occlusion / percutaneous coronary intervention / indications for intervention

References

[1] Carlino M,Uretsky BF,Walsh S.Treatment of the chronic total occlusion: a call to action for the interventional community..Catheter Cardiovasc Interv2015;85:771-8

[2] Sianos G,Galassi AR,Escaned J.Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club..EuroIntervention2012;8:139-45

[3] Christofferson RD,Martin G V,Caldwell JH.Effect of chronic total coronary occlusion on treatment strategy..Am J Cardiol2005;95:1088-91

[4] Jeroudi OM,Michael TT,Patel VG.Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital..Catheter Cardiovasc Interv2014;84:637-43 PMCID:PMC3992199

[5] Fefer P,Cheema AN,Osherov AB.Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry..J Am Coll Cardiol2012;59:991-7

[6] Galassi AR. Retrograde coronary revascularisation in Europe to treat chronic total coronary occlusions. Available from: https://cardiovascularnews.com/retrograde-coronary-revascularisation-in-europe-to-treat-chronic-total-coronary-occlusions/. [Last accessed on 18 Jul 2019].

[7] Werner GS,Ferrari M,Figulla HR.The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction..Eur Heart J2006;27:2406-12

[8] Weintraub WS.Should Chronic Total Occlusion Be Treated With Coronary Artery Bypass Grafting?.Circulation2016;133:1818-25 PMCID:PMC5505506

[9] Galassi AR,Werner GS,Tomasello SD.Retrograde Recanalization of Chronic Total Occlusions in Europe: Procedural, In-Hospital, and Long-Term Outcomes From the Multicenter ERCTO Registry..J Am Coll Cardiol2015;65:2388-400

[10] Maeremans J,Knaapen P,Avran A.The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry..J Am Coll Cardiol2016;68:1958-70

[11] Brilakis ES,Karmpaliotis D,Tsai TT.Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry)..JACC Cardiovasc Interv2015;8:245-53

[12] Galassi AR,Boukhris M,Sianos G.Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview..Eur Heart J2016;37:2692-700

[13] Brilakis ES,Rinfret S,Burke MN.A percutaneous treatment algorithm for crossing coronary chronic total occlusions..JACC Cardiovasc Interv2012;5:367-79

[14] Sapontis J,Yeh RW,Hirai T.Early Procedural and Health Status Outcomes After Chronic Total Occlusion Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures)..JACC Cardiovasc Interv2017;10:1523-34

[15] George S,Clayton TC,Cotton J.Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database..J Am Coll Cardiol2014;64:235-43

[16] Galassi AR,Costanzo L,Barrano G.Long-term clinical and angiographic results of Sirolimus-Eluting Stent in Complex Coronary Chronic Total Occlusion Revascularization: the SECTOR registry..J Interv Cardiol2011;24:426-36

[17] Stojkovic S,Dobric M,Vukcevic V.Improved Propensity-Score Matched Long-Term Clinical Outcomes in Patients with Successful Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion..Int Heart J2018;59:719-26

[18] Wijeysundera HC,Fefer P,Knudtson ML.Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions..EuroIntervention2014;9:1165-72

[19] Safley DM,Hatch J,Spertus JA.Quality of life benefits of percutaneous coronary intervention for chronic occlusions..Catheter Cardiovasc Interv2014;84:629-34 PMCID:PMC4277434

[20] Stojkovic S,Dobric M,Vukcevic V.Improved Propensity-Score Matched Long-Term Clinical Outcomes in Patients with Successful Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion..Int Heart J2018;59:719-26

[21] Christakopoulos GE,Carlino M,Roesle M.Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions..Am J Cardiol2015;115:1367-75

[22] Henriques JPS,Råmunddal T,Eriksen E.Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial..J Am Coll Cardiol2016;68:1622-32

[23] Elias J,Råmunddal T,Eriksen E.Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction..Heart2018;104:1432-38

[24] Mashayekhi K,Toma A,Ferenc M.A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC Trial..JACC Cardiovasc Interv2018;11:1982-91

[25] Werner GS,Hildick-Smith D,Sianos G.A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions..Eur Heart J2018;39:2484-93

[26] Lee SW,Ahn JM,Yun SC.Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion..Circulation2019;139:1674-83

[27] Boden WE,Teo KK,Maron DJ.Optimal medical therapy with or without PCI for stable coronary disease..N Engl J Med2007;356:1503-16

[28] Al-Lamee R,Dehbi HM,Tang K.Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial..Lancet2017;6736:1-11

[29] Neumann FJ,Ahlsson A,Banning AP.2018 ESC/EACTS Guidelines on myocardial revascularization..Eur Heart J2018;1-96

[30] Windecker S,Alfonso F,Cremer J.2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)..Eur Heart J2014;35:2541-619

[31] Arain SA.The SYNTAX Score for Chronic Total Occlusions: Building a Better Mousetrap..J Invasive Cardiol2017;29:132-3